Killing rate and growth rate comparison for newer beta-lactamase-stable oral beta-lactams against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis
- PMID: 1618006
- DOI: 10.1159/000238935
Killing rate and growth rate comparison for newer beta-lactamase-stable oral beta-lactams against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis
Abstract
A new method of data presentation that takes into account the relationship between growth and killing rate was used to evaluate the comparative in vitro bactericidal activity of cefpodoxime, cefuroxime, cefixime and an amoxicillin/clavulanic acid combination against Streptococcus pneumoniae and beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis. For each strain, the viable count decrease (log CFU/ml) after 6 h of exposure to different antibiotic concentrations was plotted against the viable count increase in the control culture, over the same time. Higher killing rates than those predicted by growth rates were defined as a positive balance; lower rates than those predicted by growth rates were defined as a negative balance. The activity of the 4 drugs against S. pneumoniae and M. catarrhalis was characterized by a positive balance. Conversely, the 3 cephalosporins showed a negative balance for H. influenzae.
Similar articles
-
[Serotype distribution and drug resistance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from nasopharynx of Uygur children].Zhonghua Er Ke Za Zhi. 2018 Apr 2;56(4):279-283. doi: 10.3760/cma.j.issn.0578-1310.2018.04.008. Zhonghua Er Ke Za Zhi. 2018. PMID: 29614568 Chinese.
-
In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.J Chemother. 1996 Jun;8(3):193-9. doi: 10.1179/joc.1996.8.3.193. J Chemother. 1996. PMID: 8808715
-
Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.J Antimicrob Chemother. 2009 Mar;63(3):511-9. doi: 10.1093/jac/dkn538. Epub 2009 Jan 27. J Antimicrob Chemother. 2009. PMID: 19174454
-
Activity of oral beta-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance.Otolaryngol Head Neck Surg. 2002 Dec;127(6 Suppl):S17-23. doi: 10.1067/mhn.2002.130029. Otolaryngol Head Neck Surg. 2002. PMID: 12511856 Review.
-
How can we predict bacterial eradication?Int J Infect Dis. 2003 Mar;7 Suppl 1:S13-20. doi: 10.1016/s1201-9712(03)90066-x. Int J Infect Dis. 2003. PMID: 12839703 Review.
Cited by
-
In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae.Eur J Clin Microbiol Infect Dis. 1998 Sep;17(9):662-5. doi: 10.1007/BF01708352. Eur J Clin Microbiol Infect Dis. 1998. PMID: 9832271
-
Study of comparative antipneumococcal activities of penicillin G, RP 59500, erythromycin, sparfloxacin, ciprofloxacin, and vancomycin by using time-kill methodology.Antimicrob Agents Chemother. 1994 Sep;38(9):2065-72. doi: 10.1128/AAC.38.9.2065. Antimicrob Agents Chemother. 1994. PMID: 7811020 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical